Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0000950123-09-033693
Filing Date
2009-08-12
Accepted
2009-08-11 20:11:58
Documents
5

Document Format Files

Seq Description Document Type Size
1 CUMBERLAND PHARMACEUTICALS / FORM 424B4 c06286b4e424b4.htm 424B4 2064472
2 GRAPHIC c06286b4c0628602.gif GRAPHIC 3768
3 GRAPHIC c06286b4c0628643.gif GRAPHIC 6950
4 GRAPHIC c06286b4c0628644.gif GRAPHIC 6473
5 GRAPHIC c06286b4c0628645.gif GRAPHIC 8587
  Complete submission text file 0000950123-09-033693.txt   2101960
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: 424B4 | Act: 33 | File No.: 333-142535 | Film No.: 091005079
SIC: 2834 Pharmaceutical Preparations